About Us

We have assembled a team of leading cell therapy scientists and drug developers. 

Team Members

Sarah Hein, PhD

CEO, Co-Founder

Maksim Mamonkin, PhD

CSO, Co-Founder

Malcolm Brenner, MD, Phd

Co-founder and Chair Scientific Advisory Board

Leah Dimascio, PhD

Chief Operating Officer

Alice Bexon

Alice Bexon, MD

Acting Chief Medical Officer

Nebojsa Milovic, PhD

Chief Technical Officer

Victoria Lake

Tory Lake, RAC

Head of Regulatory

Steve Haesshaefer, MBA

Head of Clinical Operations

Federica Giordano, PhD

Director of Clinical Operations

Eric Smith, PhD

Senior Director Research and Development

Olga Meystelman

Director of Quality

Sasha Davani

Program Manager

Peter Siapno

Patient Material Logistics Coordinator

Ragini Mistry

Scientist, Research & Development

Taylor Wolt

Research Associate II

Interested in joining the March Bioscience Team?

Board Members

Sarah Hein, PhD

Chief Executive Officer

Maksim Mamonkin, PhD

Chief Scientific Officer

Cassidy Blundell, PhD

Mission BioCapital

Owen Smith, MS, CPFA

4BIO Capital

Thomas Luby

TMC Venture Fund

Stefan Wildt, PhD

Volnay Therapeutics

Peter Olagunju, MBA

Chairman of the Board

Scientific Advisory Board

Malcolm Brenner, MD, PhD

Cofounder, Founding Director the Center for Cell and Gene Therapy, Baylor College of Medicine

Maksim Mamonkin, PhD

Associate Professor, Baylor College of Medicine

Helen Heslop, MD

Director for the Center for Cell and Gene Therapy, Baylor College of Medicine

Swaminathan Iyer, MD

Professor of Medicine, Department of Lymphoma / Myeloma, MD Anderson Cancer Center

Steven Horwitz, MD

Endowed Chair, Memorial Sloan Kettering Cancer Center

Patrick Hanley, PhD

Chief and Director, Cellular Therapy Program, Children's National Hospital - page

Aaron Vernon, MBA, MS

Chief Manufacturing Officer, Quell Therapeutics

Investors

TMC Venture logo
Small Ventures logo
Portal Innovations logo

Partners

Baylor College of Medicine Logo